Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Materials
Biobased C4 Production Advances
by Melody M. Bomgardner
December 9, 2013
| A version of this story appeared in
Volume 91, Issue 49
BASF has produced its first commercial quantities of 1,4-butanediol using fermentation technology licensed in May from biobased chemicals start-up Genomatica. BASF plans to use the butanediol, which was made from dextrose, to produce derivatives including polytetrahydrofuran. Separately, U.K.-based Green Biologics has raised $25 million in a second round of venture funding to scale up fermentation of acetone and the C4 chemical 1-butanol. The company operates a demonstration facility in Emmetsburg, Iowa, and recently purchased an ethanol plant in Little Falls, Minn.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter